NCT05395585

Brief Summary

The mode of placental delivery may contribute to an increase or decrease in the morbidity associated with CS, and many studies have shown it to be a key role in determining the blood loss during CS. Manual removal of the placenta has been implicated in increased blood loss during CS. However, other researchers concluded that it had no detrimental effect on blood loss

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 25, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 27, 2022

Completed
5 days until next milestone

Study Start

First participant enrolled

June 1, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2023

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 8, 2023

Completed
Last Updated

January 20, 2023

Status Verified

January 1, 2023

Enrollment Period

7 months

First QC Date

May 25, 2022

Last Update Submit

January 19, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Blood loss

    The blood loss during cesarean section and in the first 24 hours postoperatively will be assessed in a standard manner. Blood will be measured after suction of the mount of amniotic fluid in a separate suction bottle. Amount of blood which collected from towels will be measured according to gravimetric method which reported by Liu et al. (2020). \- EBV x (Hi-Hf)/Hi: Where the Hi is the preoperative blood hematocrit, Hf is the postoperative one and EBV is the estimated blood volume. The estimated blood volume could be calculated by multiplying weight times average blood volume which is around 65 ml/kg in females (Miller et al., 2000).

    24 hours

Study Arms (2)

Spontaneous separation

NO INTERVENTION

Manual separation

EXPERIMENTAL
Procedure: Manual placental separation

Interventions

Manual separation of the placenta from uterus

Manual separation

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age (18 - 35) years.
  • Primigravida.
  • Unscarred uterus.
  • Singleton pregnancy.
  • Living baby.
  • Body mass index (18 - 30) 37-40 weeks

You may not qualify if:

  • Emergency cesarean section due to possibility of maternal distress and blood loss.
  • Cesarean hysterectomy as the placenta will be removed with the uterus.
  • Abnormally adherent placenta: Placenta accrete, percreta or placenta previa due to failure of placental separation.
  • Previous cesarean section as the previous scar may affect placental separation.
  • Body mass index less than 18 and more than 30 as extremes of body weight may be associated with increased risks of anemia, bleeding and/or infection.
  • Suspected chorioamnionitis to decrease the risk of disseminated infection.
  • Bleeding disorders to decrease blood loss.
  • Multiple pregnancy due to larger placental volume and blood loss compared with singleton.
  • Any pelvic surgery (Appendix - Ovarian cyst. - Ectopic Pregnancy - pelvic abscess)
  • Women with medical illness e.g. pre-eclampsia, anemia (Hb less than 11 gm/dl), DM, Cardiac, Renal …etc. to decrease the risk of maternal morbidity.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University Maternity Hospital

Cairo, Cairo/القاهرة, 71350, Egypt

Location

Study Officials

  • Maii Nawara

    Ain Shams University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 25, 2022

First Posted

May 27, 2022

Study Start

June 1, 2022

Primary Completion

January 1, 2023

Study Completion

January 8, 2023

Last Updated

January 20, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will share

Locations